Novabay Pharmaceuticals Inc

Novabay Pharmaceuticals Inc

NBY

Get informed when a big investor buys or sells

+ Follow
Market Cap$39.14M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Novabay Pharmaceuticals IncNovabay Pharmaceuticals Inc0.1320%376%--
$1.23

Current Fair Value

16% downside

Overvalued by 16% based on the discounted cash flow analysis.

Share Statistics

Market cap$39.14 Million
Enterprise Value$21.37 Million
Dividend Yield$0.80 (320.00%)
Earnings per Share$-3.8
Beta0.16
Outstanding Shares26,015,000

Return

Return on Equity376.44%ROE
Return on Assets290.74%
Return on Invested Capital10.24%

Valuation & Multiples

P/E Ratio0.06P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio0.29Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT1.18
Enterprise Value to Net Income0
Total Debt to Enterprise0.03
Debt to Equity0Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
April 1, 2026
EPS Estimate
$-1.00
Average shareholder expectation
Revenue Estimate
$3.60 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %28.16%▲ 7.21%
Total Invested$2.44M▼ 92.90%
Investors Holding24▼ 2.00%

ESG Score

No data

About Novabay Pharmaceuticals Inc

CEO: Justin Hall